Literature DB >> 8873890

Discordant regulation of phenoloxidase and capsular polysaccharide in Cryptococcus neoformans.

E S Jacobson1, G M Compton.   

Abstract

We examined the regulation of two fungal virulence factors, phenoloxidase and capsular polysaccharide, in an ex-type strain of the fungal pathogen, Cryptococcus neoformans. Both were made during the stationary phase of cultural growth. Exogenous iron increased phenoloxidase activity three-fold (from 8.7 to 27.7 units mg-1, P < 0.05) but decreased capsular polysaccharide three-fold (from 9.0 to 3.4% packed cell volume, P < 0.01). A temperature shift from 25 to 37 degrees C decreased phenoloxidase activity three-fold (from 60.6 to 23.7 units mg-1, P < 0.01) but not capsular polysaccharide (8.5 to 6.7% packed cell volume, P not significant). Thus, cryptococcal virulence factors are not regulated coordinately. Moreover, although the phenoloxidase synthesizes an antioxidant, melanin, the enzyme is not induced by the oxidant, hydrogen peroxide, or by a combination of hydrogen peroxide and solubilized ferric ion. As cryptococcal melanin is cheaply made from exogenous catechols, perhaps C. neoformans does not need to regulate the phenoloxidase strongly but, rather, can afford to synthesize the phenoloxidase at a moderate rate whenever it finds its growth limited.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873890     DOI: 10.1080/02681219680000491

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  13 in total

1.  Role of the ESCRT Pathway in Laccase Trafficking and Virulence of Cryptococcus neoformans.

Authors:  Yoon-Dong Park; Shu Hui Chen; Emma Camacho; Arturo Casadevall; Peter R Williamson
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

2.  Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India.

Authors:  Piyali Mandal; Uma Banerjee; Arturo Casadevall; Joshua D Nosanchuk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection.

Authors:  George R Thompson; Nathaniel Albert; Greg Hodge; Machelle D Wilson; Jane E Sykes; Derek J Bays; Carolina Firacative; Wieland Meyer; Dimitrios P Kontoyiannis
Journal:  Infect Immun       Date:  2014-05-05       Impact factor: 3.441

Review 4.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Cryptococcus neoformans can utilize ferritin as an iron source.

Authors:  Moonyong Song; Eun Jung Thak; Hyun Ah Kang; James W Kronstad; Won Hee Jung
Journal:  Med Mycol       Date:  2022-08-09       Impact factor: 3.747

6.  Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).

Authors:  Oscar Zaragoza; Bettina C Fries; Arturo Casadevall
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 7.  Virulence-Associated Enzymes of Cryptococcus neoformans.

Authors:  Fausto Almeida; Julie M Wolf; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2015-10-09

8.  Cryptococcus neoformans requires the ESCRT protein Vps23 for iron acquisition from heme, for capsule formation, and for virulence.

Authors:  Guanggan Hu; Mélissa Caza; Brigitte Cadieux; Vivienne Chan; Victor Liu; James Kronstad
Journal:  Infect Immun       Date:  2012-11-06       Impact factor: 3.441

9.  Identification and Functional Characterization of a Cryptococcus neoformans UPC2 Homolog.

Authors:  Nam Kyun Kim; Kyunghwan Han; Won Hee Jung
Journal:  Mycobiology       Date:  2010-09-30       Impact factor: 1.858

10.  HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans.

Authors:  Won Hee Jung; Sanjay Saikia; Guanggan Hu; Joyce Wang; Carlen Ka-Yin Fung; Cletus D'Souza; Rick White; James W Kronstad
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.